top of page
Vaccine Injury Blog.jpg

Vaccine Injury Blog

Legal Disclaimer: This blog is not intended to diagnose, treat or cure a disease. Nor is it intended as medical advice. The reader is responsible for their decisions and their health.

What Causes Guillain Barre Syndrome

Writer's picture: Rawls Law GroupRawls Law Group

Although its rare and its exact cause is not definitively known, Guillain-Barre Syndrome is an autoimmune disorder that causes the body’s immune system to attack the nervous system, which can lead to lasting nerve damage.


Because of this damage to the body’s nerve cells, symptoms of Guillain-Barre Syndrome typically include weakness and numbness in the arms and legs that slowly spreads to other areas of the body. Symptoms as minor as tingling also can occur.

Most people who suffer from Guillain-Barre Syndrome develop it after recovering from an infection, such as the flu, bronchitis, or even food poisoning.

This connection to a prior infection is important. Indeed, vaccinations containing strains of infectious diseases, such as the flu shot, have been linked to the development of Guillain-Barre Syndrome, albeit in rare cases. In fact, the Centers for Disease Control and the Food and Drug Administration maintain a database of reported incidences of the development of Guillain-Barre Syndrome following vaccinations.

Thankfully, Guillain-Barre Syndrome caused by the flu vaccine is one of the injuries that the National Vaccine Injury Compensation Program identifies as deserving of monetary compensation.


Comments


CONTACT RAWLS LAW GROUP

If you choose to contact us through our website about legal services, please understand that this will not constitute an agreement to provide legal services to you, nor will such action establish an attorney-client relationship.

(804) 344-0038

211 Rocketts Way Ste 100, Henrico, VA 23231, USA

  • Google Places
  • LinkedIn
  • Instagram
  • Twitter
  • YouTube

All Rights Reserved. Privacy Policy.

© Copyright | 2023 Rawls Law Group, PC

This form no longer accepts submissions.

bottom of page